Log in to save to my catalogue

CD38 as an immunomodulator in cancer

CD38 as an immunomodulator in cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2438688843

CD38 as an immunomodulator in cancer

About this item

Full title

CD38 as an immunomodulator in cancer

Publisher

England: Future Medicine Ltd

Journal title

Future oncology (London, England), 2020-12, Vol.16 (34), p.2853-2861

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

CD38 is a transmembrane glycoprotein that is widely expressed in a variety of human tissues and cells, especially those in the immune system. CD38 protein was previously considered as a cell activation marker, and today monoclonal antibodies targeting CD38 have witnessed great achievements in multiple myeloma and promoted researchers to conduct res...

Alternative Titles

Full title

CD38 as an immunomodulator in cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2438688843

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2438688843

Other Identifiers

ISSN

1479-6694

E-ISSN

1744-8301

DOI

10.2217/fon-2020-0401

How to access this item